世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037616

日本の止血剤市場:規模、シェア、動向分析レポート、およびセグメント予測2024-2030

Grand View Research Inc.

Japan Hemostats Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2024 - 2030

発刊日 2024/03

言語英語

体裁PDF/78ページ

ライセンス/価格78ページ

0000037616

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

日本の止血剤の市場規模、シェア、動向分析レポート:製品別 (血栓系止血剤、併用止血剤)、用途別 (整形外科)、製剤別 (マトリックスおよびゲル止血剤)、最終用途別、およびセグメント別予測、2024〜2030

日本の止血剤の市場規模と動向

日本の止血剤の市場規模は、2023年に1億9,080万ドルと評価され、2024年から2030年にかけて6.40%のCAGRで成長すると予想されます。高齢人口の増加、慢性疾患の有病率の増加、日本における外科的処置数の増加などの要因によって、日本におけるさまざまな医療介入において効果的な止血ソリューションの需要が高まると予想されます。心血管疾患、癌、関節炎、骨粗鬆症、慢性呼吸器疾患、手術を必要とする神経疾患などの慢性疾患の増加が、業界の成長を促進すると予想されます。これらの疾患に関連する医学的懸念に対して、さまざまな外科的介入が利用可能です。これらの手術では、止血剤を使用して止血が行われ、市場の成長を後押しします。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Japan Hemostats Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of chronic conditions
3.2.1.2. Rising geriatric population
3.2.1.3. Increasing number of surgeries
3.2.2. Market Restraint Analysis
3.2.2.1. Product recall & failure
3.3. Japan Hemostats Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape

Chapter 4. Japan Hemostats Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Japan Hemostats Market: Product Movement Analysis & Market Share, 2023 & 2030
4.3. Japan Hemostats Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Thrombin-based Hemostats
4.4.1. Thrombin-based Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Oxidized Regenerated Cellulose-Based Hemostats
4.5.1. Oxidized Regenerated Cellulose-Based Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Combination Hemostats
4.6.1. Combination Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Others
4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Japan Hemostats Market: Formulation Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Japan Hemostats Market: Formulation Movement Analysis & Market Share, 2023 & 2030
5.3. Japan Hemostats Market Size & Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
5.4. Matrix and Gel Hemostats
5.4.1. Matrix and Gel Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Sponge Hemostats
5.5.1. Sponge Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Powder Hemostats
5.6.1. Powder Hemostats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Japan Hemostats Market: End-use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Japan Hemostats Market: End-use Movement Analysis & Market Share, 2023 & 2030
6.3. Japan Hemostats Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
6.4. Hospitals & Clinics
6.4.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Casualty Care Centers
6.6.1. Casualty Care Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Japan Hemostats Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Japan Hemostats Market: Application Movement Analysis & Market Share, 2023 & 2030
7.3. Japan Hemostats Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
7.4. Orthopedic Surgery
7.4.1. Orthopedic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. General Surgery
7.5.1. General Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Neurological Surgery
7.6.1. Neurological Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Cardiovascular Surgery
7.7.1. Cardiovascular Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Others
7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. Johnson & Johnson Services, Inc.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. CryoLife, Inc
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Integra LifeSciences Corporation
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Cohera Medical, Inc.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Pfizer
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Cohesion Technologies
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. B. Braun Melsungen AG
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Baxter
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Medtronic
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. BD
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Japan hemostats market, by product, 2018 - 2030 (USD Million)
Table 4 Japan hemostats market, by end-use, 2018 - 2030 (USD Million)
Table 5 Japan hemostats market, by application, 2018 - 2030 (USD Million)
Table 6 Japan hemostats market, by formulation, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Surgical sealing and adhesives market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Japan hemostats market, product outlook key takeaways (USD Million)
Fig. 12 Japan hemostats market: product movement analysis (USD Million), 2023 & 2030
Fig. 13 Thrombin-based hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Oxidized regenerated cellulose-based hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Combination hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Japan hemostats market, end-use outlook key takeaways (USD Million)
Fig. 18 Japan hemostats market: end-use movement analysis (USD Million), 2023 & 2030
Fig. 19 Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Casualty care centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Japan hemostats market, application outlook key takeaways (USD Million)
Fig. 24 Japan hemostats market: application movement analysis (USD Million), 2023 & 2030
Fig. 25 Orthopedic surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 General surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Neurological surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Cardiovascular surgery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Japan hemostats market, formulation outlook key takeaways (USD Million)
Fig. 31 Japan hemostats market: formulation movement analysis (USD Million), 2023 & 2030
Fig. 32 Matrix and gel hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Sponge hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Powder hemostats market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)

この商品のレポートナンバー

0000037616

TOP